Zhangzhou Pientzehuang Pharmaceutical | 600436 - Stammkapital

Aktienkurs
152.69
Täglich Wechseln
0.63 0.41%
Monatlich
-7.95%
Jährlich
-25.94%
Q1 Prognose
152.81




Stammkapital Veränderung Datum
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Cspc Pharmaceutical CNY 11.52B 486M 2025-06
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Jiangsu Hengrui CNY 6.64B 0 2025-09
Kangmei Pharma CNY 13.83B 34.97M 2025-09
Moderna USD 391M 2M 2025-09
Revvity USD 113.38M 2.7M 2025-12
Sh Fosun Pharma CNY 2.67B 0 2025-09
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Wuxi Apptec CNY 2.98B 123.4M 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2025-09